Picture of Sun Pharmaceutical Industries logo

SUNPHARMA — Sun Pharmaceutical Industries News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Preview: India's Sun Pharmaceutical inches higher ahead of Q1 results

BUZZ-PREVIEW-India's Sun Pharmaceutical inches higher ahead of Q1 results

** Shares of Sun Pharmaceutical Industries SUN.NS rise 0.6% to 2,013.10 rupees

** Analysts on avg expect pharmaceuticals co to post a 31.2% Y/Y growth in Q1 consol net profit to 29.9 bln rupees ($312.5 mln)

** Analysts on avg expect SUN's consol revenue to rise 11.8% y/y to 155 bln rupees

** Brokerage ICICI Securities expects revenue growth to be led by steady traction in India formulations and scale-up in specialty portfolio

** HDFC Securities says US generic business is expected to remain flat Q/Q, sharp decline Y/Y due to absence of gRevlimid

** PL Capital says revenue growth to be led by specialty and domestic segments with moderate EBITDA growth

** PhillipCapital says margins to decline to 26.8% on account of speciality related launch cost in the US

** YTD, SUN up 17.1% vs pharma index's .NIPHARM ~17% rise


($1 = 95.6800 Indian rupees)


(Reporting by Vijay Malkar and Kashish Tandon)

((VijayDattaram.Malkar@thomsonreuters.com;))

Recent news on Sun Pharmaceutical Industries

See all news